LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

Kodu・Aktsiate loetelu・Dynavax Technologies Corp

Dynavax Technologies Corp

Suletud

SektorTervishoid

10.96 0.64

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

10.84

Max

11.17

Põhinäitajad
By Trading Economics
Sissetulek	8.2M 27M
Müük	-566K 95M
P/E Sektori keskmine	58.75 80.03
Kasumimarginaal	28.381
Töötajad	405
EBITDA	7M 32M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+86.87% upside

Turustatistika
By TradingEconomics
Turukapital	63M 1.3B
Eelmine avamishind	10.32
Eelmine sulgemishind	10.96

Uudiste sentiment

By Acuity

31%

69%

77 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

9.62 / 10.9 Toetus ja vastupanu

Dynavax Technologies Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. dets 2025, 23:48 UTC

Suurimad hinnamuutused turgudel

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

8. dets 2025, 23:44 UTC

Market Talk

Perky Australian Dollar Looks to Extend Gains -- Market Talk

8. dets 2025, 23:42 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

8. dets 2025, 23:13 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. dets 2025, 23:13 UTC

Market Talk

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

8. dets 2025, 23:09 UTC

Omandamised, ülevõtmised, äriostud

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

8. dets 2025, 22:46 UTC

Market Talk

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

8. dets 2025, 22:01 UTC

Market Talk

Miners Poised to Do Well in 2026 -- Market Talk

8. dets 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

8. dets 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

8. dets 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

8. dets 2025, 22:00 UTC

Omandamised, ülevõtmised, äriostud

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

8. dets 2025, 21:51 UTC

Market Talk

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

8. dets 2025, 21:50 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Tech, Media & Telecom Roundup: Market Talk

8. dets 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

8. dets 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. dets 2025, 21:38 UTC

Omandamised, ülevõtmised, äriostud

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

8. dets 2025, 21:38 UTC

Omandamised, ülevõtmised, äriostud

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

8. dets 2025, 21:36 UTC

Market Talk

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

8. dets 2025, 21:20 UTC

Omandamised, ülevõtmised, äriostud

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

8. dets 2025, 21:12 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8. dets 2025, 21:08 UTC

Market Talk

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

8. dets 2025, 20:38 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

8. dets 2025, 20:26 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8. dets 2025, 20:18 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

8. dets 2025, 20:07 UTC

Market Talk

Oil Futures Snap Three-Session Winning Streak -- Market Talk

8. dets 2025, 20:06 UTC

Market Talk

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

8. dets 2025, 20:05 UTC

Market Talk

Global Equities Roundup: Market Talk

8. dets 2025, 20:05 UTC

Market Talk

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

8. dets 2025, 20:01 UTC

Market Talk

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Dynavax Technologies Corp Prognoos

Hinnasiht

By TipRanks

86.87% tõus

12 kuu keskmine prognoos

Keskmine 20.5 USD 86.87%

Kõrge 25 USD

Madal 16 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Dynavax Technologies Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Dynavax Technologies Corp aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

9.62 / 10.9Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

77 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.